« Back to Record
Citation APA

Mathieu, M., El Oumeiri, B. G., Thoma, P., Metens, T., Touihri, K., Hadad, I., Ray, L., Mazouz, N., De Lavareille, A., Willemsen, P., Naeije, R., Heyndrickx, G., Bartunek, J., & McEntee, K. (2008). Functional Improvement After Bone Marrow-Derived Mononuclear Versus Nonmodified Mesenchymal Stem Cell Therapy in Chronic Myocardial Infarction. Functional Improvement After Bone Marrow-Derived Mononuclear Versus Nonmodified Mesenchymal Stem Cell Therapy in Chronic Myocardial Infarction. Vol. 51 (p. 183) American College of Cardiology Congress(Mars 2008: Chicago).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/205040

Mathieu, M., El Oumeiri, B. G., Thoma, P., Metens, T., Touihri, K., Hadad, I., Ray, L., Mazouz, N., De Lavareille, A., Willemsen, P., Naeije, R., Heyndrickx, G., Bartunek, J., & McEntee, K. (2008). Functional Improvement After Bone Marrow-Derived Mononuclear Versus Nonmodified Mesenchymal Stem Cell Therapy in Chronic Myocardial Infarction. Functional Improvement After Bone Marrow-Derived Mononuclear Versus Nonmodified Mesenchymal Stem Cell Therapy in Chronic Myocardial Infarction. Vol. 51 (p. 183) American College of Cardiology Congress(Mars 2008: Chicago).